|
Market Closed -
London S.E.
12:35:04 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 2,050.00 GBX | +3.02% |
|
+5.13% | +7.61% |
| 10-26 | EARNINGS AND TRADING: Quadrise starts strategic review as losses mount | AN |
| 10-26 | Bioventix PLC Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOVENTIX PLC | Other Biotechnology & Medical Research | +3.02% | +5.13% | +7.61% | +11.72% | -43.06% | 138M |  | | |
- Stock Market
- Stocks
- BVXP Stock
- Charts Bioventix PLC
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
